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ABSTRACT
Background: In previous studies, several strains of mice were used as chemical-induced skin irritation mod-
els to identify immunological hazards and elucidate the molecular and cellular mechanisms by which irritant
dermatitis disease occur. BALBc and C57BL6 mice have been used for most of these experiments. Although
there are some differences in the immune response to chemical allergens between these strains, few studies
have been conducted to determine what regulatory factors contribute to these variations.
Methods: To investigate the cause of high responses to skin irritation in C57BL6 mice that are widely used to
study atopic dermatitis, changes in various immune-related factors such as ear thickness, myeloperoxidase ac-
tivity, lymph node weight, IgE concentration and cytokine concentration were measured in C57BL6 and
BALBc mice following phthalic anhydride (PA) treatment.
Results: Based on analysis of the skin irritation, C57BL6 mice showed a greater skin irritation to PA than
BALBc mice, although the IgE concentration and auricular lymph node weight did not contribute to this differ-
ence in the response. However, the concentration of several cytokines and chemokines (interleukin [IL]-6 and
vascular endothelial growth factor [VEGF], keratinocyte-derived chemokine [KC] and regulated on activation
normal T cell expressed and secreted [RANTES]) were significantly higher in C57BL6 mice than BALBc mice
following treatment with PA.
Conclusions: Our results suggest that several of the cytokines and chemokines secreted from irritant site
could contribute to the regulation mechanism responsible for the difference in the skin irritation among various
strains of mice following exposure to PA.
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INTRODUCTION
Phthalic anhydride is the organic compound and an
important industrial chemical, especially for the large-
scale production of plasticizers for plastics. Also,
phthalic anhydride is known to provokes a strong irri-
tant dermatitis associated with skin inflammation.1 Al-
lergic diseases, which are defined by the production
of IgE in response to environmental antigens, can
lead to asthma, rhinitis, atopic dermatitis and contact
dermatitis. These disorders affect 10-15% of western
populations, and their prevalence has doubled in the
last 10-15 years.2 This increase has included allergic
skin disorders such as atopic or contact dermatitis ac-
companied by irritant dermatitis in the site at which
contact with an allergen has occurred.3 Such inflam-
matory responses are characterized by infiltration by
specific cells, including inflammatory cells such as T
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lymphocytes, leukocytes, neutrophils, eosinophils,
macrophages, mast cells and regulatory and natural
killer T cells.4,5 Furthermore, activation of inflamma-
tory cells by this infiltration is mediated by various
cytokines and chemokines at the site of injury. For
example, interleukin (IL)-6 is produced at the site of
inflammation and plays a key role in the skin inflam-
mation by increasing the mononuclear cell infiltrate.4
Additionally, chemokines such as keratinocyte-
derived chemokine (KC) and regulated on activation
normal T cell expressed and secreted (RANTES)
were recently found to be the most potent molecules
involved in the regulation of selective recruitment of
inflammatory cells. Moreover, these molecules were
found to direct the migration of inflammatory cells
into inflammatory foci.6 In the serum, the concentra-
tion of RANTES has been shown to increase in atopic
dermatitis patients when compared with normal con-
trols, and this increase has been shown to augment
the production of RANTES that are correlated with ir-
ritant dermatitis associated with atopic dermatitis.7
In previous studies, several strains of mice were
used as chemical-induced skin irritation models to
identify immunological hazards and elucidate the mo-
lecular and cellular mechanisms by which irritant
dermatitis disease occur. BALBc and C57BL6 mice
have been used for most of these experiments8; how-
ever, there are some differences in the immune re-
sponse to chemical allergens between these models.
In addition, it has been demonstrated that BALBc
mice are immunoglobulin (Ig) E high responders,
while C57BL6 mice are IgE low responders.5,9 De-
spite the differences in this model of inbred mice, few
studies have been conducted to determine what regu-
latory factors contribute to these variations. In this
study, PA treatment was found to induce skin irrita-
tion response in both C57BL6 and BALBc mice,
but the response was greater in C57BL6 mice than
in BALBc mice. To investigate the mechanism of
these responses, the IgE concentration and lymph
node weight in both groups of mice was measured
following PA treatment; however, these factors did
not contribute to different skin irritation response be-
tween the two stains. Therefore, the levels of several
cytokines and chemokines were evaluated. The re-
sults revealed that there were significantly higher lev-
els of these cytokines in C57BL6 mice than BALBc
mice following PA treatment. Considering our re-
sults, we concluded that skin irritation response in
C57BL6 mice is more sensitive than that of BALBc
mice, while allergic response in BALBc mice is
greater than that of C57BL6 mice. Taken together,
the cytokines and chemokines identified in this study
may be useful in the development of methods to treat
atopic and contact dermatitis.
METHODS
CARE AND USE OF MICE
Female C57BL6 and BALBc mice (6-8 weeks old),
which are usually used to evaluate the response to al-
lergens at our institution, were used in this study. All
mice were supplied by the breeding center of our fa-
cility and were handled in a Korea Food and Drug
Administration (FDA) accredited animal facility in ac-
cordance with the AAALAC International Animal
Care policy (Accredited Unit, Korea Food and Drug
Administration: Unit no. 000996). Mice were housed
in cages under a strict light cycle (lights on at 06 : 00
hr and off at 18 : 00 hr) and temperature (23 ± 1℃).
In addition, all mice were provided with a standard ir-
radiated chow diet (Purina Mills Inc., Korea) ad libi-
tum and maintained in a specified pathogen-free
state.
EXPERIMENTAL DESIGN AND ALLERGIC SKIN
INFLAMMATION INDUCED BY PA TREATMENT
First, 6-8 week old female C57BL6 and BALBc
mice were randomly divided into two subgroups (n =
8) per strain. In the first subgroup (AOO), 40 μl of
acetone-olive oil were repeatedly spread on the dor-
sum of the ear and the shaved back skin of C57BL6
and BALBc mice 3 times a week for 4 weeks. In the
second subgroup (PA), 40 μl of 5% PA solution in ve-
hicle (4 : 1 acetone-olive oil, vv: AOO) were repeat-
edly spread on the dorsum of the ear and the shaved
back skin of C57BL6 and BALBc mice 3 times a
week for 4 weeks.
MEASUREMENT OF EAR THICKNESS AND SKIN
SCORE
The ear thickness and skin scores of the mice were
measured to determine the degree of irritant dermati-
tis induced by PA treatment. Briefly, a thickness
gauge (Digimatic Indicator, Mitutoyo, Tokyo, Japan)
was used to measure the thickness of the ear. The in-
crease in ear thickness was then determined by sub-
tracting the ear thickness prior to the first treatment
from the thickness at the time of the treatment. In ad-
dition, changes in the skin on the dorsum of the ear
and the back skin of mice were observed weekly us-
ing the method described in a previous study.10 In
this method, the degree of four characteristics,
erythemahemorrhage, edema, excoriationerosion
and dryness, were scored from 0 points (none) to 3
points (severe) depending on the severity of the der-
matitis. Finally, the total skin score was calculated
from the sum of the scores of the four characters.
DETECTION OF SERUM IgE CONCENTRATION
The serum IgE concentration was measured using an
enzyme-linked immunosorbent assay kit (Shibayagi,
Inc., Gunma, Japan) according to the manufacturer’s
instructions. Briefly, capture antibodies were plated
Differential Irritant Dermatitis to PA
Allergology International Vol 59, No4, 2010 www.jsaweb.jp 391
in a Nunc C bottom immunoplate supplied in the kit
and then incubated for 1 hr at room temperature.
Next, the wells were washed with washing solution
(50 mM Tris, 0.14 M NaCl, 0.05% Tween 20, pH 8.0)
three times, after which 200 μl of blocking solution
(50 mM Tris, 0.14 M NaCl, 1% BSA, pH 8.0) were
added to each well. After incubation for 30 min at
room temperature, the wells were washed three
times with washing solution. Next, the serum sam-
ples and standards diluted 20-fold with dilution solu-
tion were added to the wells, and the plate was then
incubated for 1 hr. The wells were then washed with
washing solution, after which horseradish peroxi-
dase-conjugated detection antibodies were diluted
5000-fold with conjugate diluent (50 mM Tris, 0.14 M
NaCl, 1% BSA, 0.05% Tween 20, pH 8.0) and trans-
ferred to each well. The plates were then incubated at
room temperature for 1 hr, after which they were
washed three times with washing solution. An en-
zyme reaction was then initiated by adding substrate
solution and incubating the plate at room tempera-
ture in the dark for 30 min. Finally, the reaction was
terminated by adding 2 M H2SO4 solution, and the
absorbance at 450 nm was measured.
HISTOLOGICAL ANALYSIS
The ear skins were removed from mice, fixed with
10% formalin, embedded in paraffin wax, routinely
processed and then sectioned into 5 μm thick slices.
The skin sections were then stained with hematox-
ylin and eosin and examined by light microscopy for
the presence of edema and inflammatory cell accu-
mulation.
MYELOPEROXIDASE (MPO) ACTIVITY
The ears were homogenized in 1 ml of T-PER protein
extraction reagent (Pierce, Rockford, IL, USA) con-
taining a protease inhibitor cocktail. The homogen-
ates were then centrifuged at 16,000 × g for 30 min,
after which the MPO activity was measured using an
enzyme-linked immunosorbent assay kit (Hycult
Biotechnology, Uden, The Netherlands) according to
the manufacturer’s instructions. The protein content
of the homogenates was then measured using a Bio-
Rad protein assay kit (Bio-Rad Laboratories, CA,
USA) according to the manufacturer’s instructions,
after which the MPO activity was normalized based
on the protein contents.
MOUSE CYTOKINE ARRAY ASSAY
Mouse cytokines were analyzed in the lysate of ear
tissues. The tissues was lysed in 100 μl of protein ex-
traction buffer (PRO-PREP, Intron, Seoul, Korea)
with sonicator (Ultra-Turrax-25, Ika-Werke, USA).
And a lysate were collected from the sonicator mix-
ture using the centrifugation and stored at -70℃ until
further analyses.
Furthermore, the expression profiles of several cy-
tokines derived from the lysate were then evaluated
using a mouse cytokine array assay kit (RayBiotech,
Norcross, GA, USA) according to the manufacturer’s
instructions. Briefly, the slides of the cytokine array
were blocked with 5% BSATBS (0.01 M Tris HCl pH
7.6, 0.15 M NaCl) for 1 hr. Next, 50 μl of the superna-
tants and lysates corresponding to each mouse strain
were added to this slide, which was then incubated at
room temperature for 30 minutes. After extensive
washing with Tris buffer saline (TTBS) containing
0.1% Tween 20 (3 times, 5 min each) and TBS (2
times, 5 min each) to remove the unbound materials,
the slide was incubated with a cocktail of biotin-
labeled antibodies against different individual cytoki-
nes. The membranes were then washed and incu-
bated with HRP-conjugated streptavidin (2.5 pgml)
for 1 hr at room temperature. Next, the unbound
HRP-streptavidin was washed out with TTBS and
TBS. Finally fluorescent detection was performed us-
ing the Cy3 wavelength (550 nm) of a laser scanner
(GenePix 4000B, Axon Instrument, Sunnyvale, CA,
USA).
WESTERN BLOT
Protein samples were separated by SDS-polyacryla-
mide gel electrophoresis (SDS-PAGE) on 10%
acrylamide gel and then transferred to nitrocellulose
membranes (Amersham, UK) for 1 h at 300 mA in
transblotting buffer (0.2 M glycine-HCl, 25 mM Tris-
base, and 20% (v v-1) methanol). To block non-specific
antibody binding, membranes were incubated for 1 h
in blocking buffer (PBS pH7.4, 0.1% Tween-20) con-
taining 5% (w v-1) non-fat dry milk. Membranes were
then incubated overnight at 4℃ with the IL-6 polyclo-
nal antibody (Santa Cruz, CA, USA) or VEGF polyclo-
nal antibody (Peprotech, NJ, USA) used at a dilution
of 1 : 1000 in blocking buffer where non-fat milk was
replaced with 5% BSA. Membranes were washed with
blocking buffer for 3 × 5 min and incubated with 1 :
1500 dilution of alkaline phosphatase-conjugated anti-
rabbit secondary antibody, washed and protein detec-
tion was carried out using CDPStarTM chemilumines-
cent reagent. Membranes were drained from excess
developing solution and exposed to Kodak X-OMAT-
S film.
STATISTICAL ANALYSIS
One-way ANOVA was used to determine if significant
differences existed between PA treated and AOO
treated mice (SPSS for Windows, Release 10.10, Stan-
dard Version, Chicago, IL, USA). In addition, differ-
ences in the responses of C57BL6 and BALBc mice
were evaluated using a Post-Hoc test (SPSS for Win-
dows, Release 10.10, Standard Version) of the vari-
ance and significance levels. All values are reported
as the mean ± SEM. A p value of <0.05 was consid-
ered significant.
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Fig. 1 Diferences in the response of C57BL/6 and 
BALB/c mice to PA treatment based on the ear thickness 
and skin score. PA solution was repeatedly applied to the 
dorsum of the ear and shaved back skin of C57BL/6 and 
BALB/c mice. After 4 weeks, the diference in the skin irita-
tion between C57BL/6 and BALB/c mice was determined 
based on the ear thickness (A) and back skin score (B) us-
ing the procedure described in the Methods. Data shown 
are the means ± SEM (n = 6-8). *p < 0.05 when compared 
with BALB/c mice (One-way ANOVA).
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RESULTS
INDUCTION OF AN ALLERGIC SKIN INFLAMMA-
TION BY PA TREATMENT
It has previously been reported that PA induced a
skin irritation in various strains of mice.1,11 Therefore
to investigate the difference in the skin irritation re-
sponse between BALBc and C57BL6 mice, indica-
tors of skin irritation including ear thickness, skin
score and myeloperoxidase (MPO) activity were
measured in both strains of mice following topical ap-
plication of PA solution for 4 weeks. First, the ear
thickness was measured in the ears of both C57BL6
and BALBc mice using a thickness gauge. As shown
in Figure 1A, the ear thickness of both mice in-
creased steadily in the PA-treatment group with time,
while it did not change in the AOO-treatment group.
In addition, the rate of the increase in ear thickness
was greater in C57BL6 mice than in BALBc mice in
the PA-treatment group. Second, the skin score was
used to determine the degree of the erythemahem-
orrhage, edema, excoriationerosion and dryness on
the back skin of both C57BL6 and BALBc mice.
Following PA treatment, the skin scores increased
significantly in both strains of mice; however, the rate
of increase was higher in C57BL6 mice than in
BALBc mice (Fig. 1B).
Next, to identify the induction of the skin irritation,
histological analysis of the ear tissue of C57BL6 and
BALBc mice was performed. Potent inflammatory
changes were observed in the PA treatment group,
but not in the AOO treatment group. Furthermore, in
the PA treatment group, the edema, epidermal hyper-
plasia and a large number of inflammatory cells were
detected in both strains of mice (Fig. 2). However,
enumeration of the infiltration of inflammatory leuko-
cytes into the dermis revealed that these changes
were more apparent in C57BL6 mice than in BALB
c mice. Finally, neutrophils infiltration was detected
in the ear homogenates of both mice, which indicates
that neutrophils infiltration was involved in the in-
flammatory process. In this process, neutrophils de-
stroy infectious pathogens via the specific enzyme,
MPO, which catalyzes the reaction of hydrogen per-
oxide with chloride ions to produce the strongly anti-
septic hypochlorite ion. Therefore, the magnitude of
neutrophil infiltration was indirectly detected as the
measured quantity of the MPO activity.12 In the pre-
sent study, MPO activity increased in the PA treat-
ment group, but was unchanged in the AOO treat-
ment group. Furthermore, the increase in MPO activ-
ity that was observed in the PA treated group was
greater in C57BL6 mice than in BALBc mice (Fig.
3). Taken together, these results suggest that PA
treatment led to a significant increase in skin irrita-
tion in both strains of mice. However, these re-
sponses were more sensitive in C57BL6 mice than
in the BALBc mice.
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Fig. 2 Diferences in the response of C57BL/6 and BALB/c mice to PA treatment based on the 
histopathology. PA solution was repeatedly applied to the dorsum of the ear and the shaved back of 
C57BL/6 (A) and BALB/c (B) mice. After 4 weeks, histological changes were determined as described in 
the Methods. The slide sections of ear tissue were stained with hematoxylin & eosin and observed at the 
original magnification ×100 or ×200. In addition, the rectangle in A-b and B-b indicated the area of A-c 
and B-c showing the enlargement. The scale bar in A-a, A-b, B-a and B-b indicate 100 μm, while it indi
cates 50 μm in A-c and B-c.
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CHANGES IN THE WEIGHT OF THE AURICULAR
LYMPH NODE AND SERUM IgE CONCENTRA-
TION FOLLOWING PA TREATMENT
Next, we investigated whether the cause of differ-
ences in the skin irritation between C57BL6 and
BALBc mice is different allergic response. To ac-
complish this, we evaluated the auricular lymph node
weight and serum IgE concentration in both strains
of mice. It is well known that the weight of the local
lymph node increases in response to topical applica-
tion of agents that have allergenic or sensitizing po-
tential.13 In this study, PA treatment was found to in-
duce an increase in the auricular lymph node weight
in both strains of mice; however, no change in weight
was observed in response to AOO treatment. Addi-
tionally, the weight of the auricular lymph node was
greater in BALBc mice than in C57BL6 mice (Fig.
4A).
It is well known that the hyperproduction of IgE is
one of the characteristic features of allergic hypersen-
sitivity14 and an indicator of the magnitude of allergic
immune response.9 Therefore, the serum IgE con-
centration was measured in both strains of mice at
different time points to determine if it contributed to
the difference in their response to PA treatment. As
shown in Figure 4B, repeated topical application of
PA solution induced a significant increase in serum
IgE concentrations in both C57BL6 and BALBc
mice after PA treatment. However, no changes in the
IgE concentration were observed in the AOO treat-
ment group. Moreover, the BALBc mice in the PA
Bae CJ et al.
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Fig. 3 Diferences in the response of C57BL/6 and 
BALB/c mice to PA treatment based on the MPO activity. PA 
solution was repeatedly applied to the dorsum of the ear and 
the shaved back skin of C57BL/6 and BALB/c mice. After 4 
weeks, to measure the MPO activity, the ear tissue was ex-
cised from the mice and homogenized, after which the MPO 
activity was determined as described in the Methods. Data 
shown are the means ± SEM (n = 6-8). *p < 0.05 when com-
pared with BALB/c mice (One-way ANOVA).
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Fig. 4 Changes in the auricular lymph node weight and se-
rum IgE concentration in C57BL/6 and BALB/c mice folow-
ing PA treatment. After PA treatment, the mice were 
sacrificed under anesthesia. The auricular lymph nodes (A) 
were then harvested from the neck region of the mice using 
a microscissor, after which they were weighed using a 
chemical balance. The serum used to measure the IgE con-
centration (B) was prepared from blood samples colected 
from the abdominal vein of the mice. The IgE concentration 
in serum was quantified by an enzyme-linked immuno-
sorbent assay. Data shown are the means ± SEM (n = 6-8). 
*p < 0.05 when compared with BALB/c mice (One-way 
ANOVA).
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treatment group were found to have a higher IgE
concentration than the C57BL6 mice (Fig. 4B).
Taken together, these results suggest that the in-
crease in auricular lymph node weight and IgE con-
centration did not contribute to the skin irritation that
was observed in C57BL6 mice in response to PA
treatment.
CHANGES IN THE EXPRESSION OF CYTOKINES
AND CHEMOKINES FOLLOWING PA TREAT-
MENT
It has been reported that several cytokines and
chemokines could regulate the irritant dermatitis.15
Therefore, to investigate another cause of the differ-
ence in the skin irritation response between BALBc
and C57BL6 mice, the expression levels of cytokines
and chemokines were analyzed in the lysate of ear tis-
sue in C57BL6 and BALBc mice using cytokine ar-
ray assay. After PA treatment, the level of several cy-
tokines and chemokines were significantly increased
in both C57BL6 and BALBc mice, while others de-
creased in both strains. However, AOO treatment did
not induce any alteration of many cytokines and
chemokines (data not shown). Especially, four cytoki-
nes and chemokines including IL-6, VEGF, KC and
RANTES in all analyzed factors were selected a target
for investigating a clue of differential response be-
tween C57BL6 and BALBc mice. The expression
level of these four members was greatly increased in
both strains of mice after PA treatment. But, the rate
of increase of these four members in response to PA
treatment was greater in C57BL6 mice than in
BALBc mice (Fig. 5A). Furthermore, to make sure
these alterations, the protein level of IL-6 and VEGF
were directly confirm with the specific antibody for
IL-6 and VEGF. Western blot analysis showed that
the expression level of these two proteins were
higher in C57BL6 mice than that of BALBc mice
(Fig. 5B). As time goes on, the expression level of
two proteins were markedly increased. The highest
level of these proteins was detected at 4-weeks after
PA treatment. Taken together, these results suggest
that four cytokines and chemokines may contribute
to the difference in the level of skin irritation that is
observed in C57BL6 mice when compared to
BALBc mice following PA treatment.
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Fig. 5 Diferences in the response of cytokine expression in ear tissue between C57BL/6 and 
BALB/c mice folowing PA treatment. Ear tissues were lysed in 500 μL of protein extraction bufer 
by sonication. The lysates were then colected from the total sonicated-extract and used for a 
mouse cytokine aray assay (A) and western blot (B) as described in the Methods. *p < 0.05 when 
compared with BALB/c mice (One-way ANOVA).
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DISCUSSION
Irritant dermatitis occurs as a result of xenobiotic
chemicals penetrating the skin and chemically react-
ing with self proteins, which results in a hapten-
specific immune response.16 In the present study, we
observed a difference in the level of skin irritation be-
tween C57BL6 mice and BALBc mice. Specifically,
the ear thickness and back skin score revealed that
C57BL6 mice were more sensitive to PA treatment
than BALBc. We also found that the difference in
the skin irritation between C57BL6 mice and BALB
c mice originated from differences in the expression
of several cytokines. To evaluate the magnitude of
the local immune reaction of mice in response to topi-
cal application of PA, we evaluated the increase in
auricular lymph node weight and serum IgE levels.
Allergic response to chemical allergens is generally
acknowledged to be dependent on IgE-mediated
mechanisms, and the hyper-production of IgE is one
of the most characteristic features of allergic re-
sponse14; however, there are differences among spe-
cies. Because the auricular lymph node weight and
serum IgE levels in BALBc mice were higher than
the levels in C57BL6 following PA treatment, we
concluded that the magnitude of the local allergic re-
action did not affect the severity of the skin irritation.
Irritant dermatitis is typically characterized by the
infiltration of inflammatory cells.4 Several cytokines
and chemokines mediate this infiltration and activa-
tion of these inflammatory cells at the site of injury.15
As seen in Figure 5, the expression of VEGF, KC, and
Bae CJ et al.
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RANTES in the ear tissue of C57BL6 and BALBc
mice increased following treatment with PA solution.
However, a greater increase in these cytokines and
chemokines was observed in C57BL6 mice than in
BALBc mice. Also, IL-6 increased in only C57BL6
mice following PA treatment. These findings indicate
that these cytokines and chemokines play a role in
the degree of skin irritation.
IL-6 is induces the infiltration of mononuclear cell
and is believed to play an important role in ongoing
chronic skin irritation.4,17 VEGF is a potent mediator
of angiogenesis that stimulates the migration and pro-
liferation of endothelial cells, increases vascular per-
meability and stimulates the expression of interacel-
lular adhesion molecules (ICAM)-1 and vascular cell
adhesion molecule (VCAM)-1 on endothelial
cells.18-20 Moreover, it has been reported that overex-
pression of VEGF in the skin of K14VEGF trans-
genic mice induces an increase in ear thickness, epi-
dermal thickness, angiogenesis and infiltration of T
cells.21 KC contributes to neutrophil chemotaxis and
activation in rodent model of acute inflammation.22
RANTES belongs to the CC-chemokine family, which
induce eosinophil migration into local tissue.23 These
findings explain the observation that the infiltration of
inflammatory leukocyte into the dermis was greater
in C57BL6 mice than in BALBc mice following
treatment with PA (Fig. 2).
The results of previous studies have demonstrated
that both environmental and genetic factors play a
role in the pathogenesis of chronic irritant dermatitis
and inflammation diseases such as asthma and atopic
dermatitis.24,25 Furthermore, polymorphisms and mu-
tations of the genes encoding several cytokines are
known to influence the progression of irritant derma-
titis and inflammation diseases. Moreover, mutations
that affect the function of the promoter region of the
RANTES and type 2 helper T cell cytokines have
been identified in patients with Alzheimer’s disease.26
Based on these findings and the results of the pre-
sent study, we suggest that such genetic variations
may result in differences in the level of cytokine ex-
pression in C57BL6 and BALBc mice, which could
subsequently lead to differences in the skin irritation
response.
In conclusion, the results of this study suggest that
the difference in skin irritation response between C57
BL6 mice and BALBc mice did not occur due to dif-
ferences in the magnitude of local allergic response,
but that they did occur in response to differences in
the expression of several cytokines and chemokines.
Additionally, these biased expressions of cytokines
among strains of mice suggest that modulation of
these factors may have therapeutic potential for the
treatment of chronic skin disease.
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